All lobbying filings
Actum I, LLC
Actum I, LLC filed a Q4 termination report for Prio Pharma, Inc. on January 21, 2026, reporting $10,000 in lobbying income.
Lobbying for Prio Pharma, Inc. · pharmaceutical company
Filing · LD-2 quarterly report
Q4 termination
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 21, 2026
Income
$10,000
What the client paid this registrant for the period.
Client based in
California
Representation ended
Dec 31, 2025
The registrant reported terminating its work for this client.
Lobbyists on this filing
3
-
LAUREN LIPINPreviously held: Mil Leg Asst/Leg Corresp. Cong. C.A. Dutch Ruppersberger
-
KEVIN KELLYPreviously held: Chief Counsel/Floor Asst, Sec of the Democratic Conference; Chief Clerk/Maj Staff Dir, Senate VA/HUD Approps Subcomm
-
JEFFREY REGANPreviously held: Leg Asst/Policy Advisor, Leg Aide, Leg Corresp., Staff Assistant - Sen. Christopher Dodd
Government bodies contacted
3
Lobbying activity
2
FY26 Defense Appropriations bill - Defense Health Program funding; H.R.5371 - Continuing Appropriations and Extensions Act, 2026, S.2882 - Continuing Appropriations and Extensions and Other Matters Act, 2026; FY2026 Continuing Appropriations, Agriculture, Leg. Branch & Extensions Act P.L. 119-37
FY26 Defense Appropriations bill - Defense Health Program funding; FY26 National Defense Authorization Act (P.L. 119-60)